CD40/CD40L and Related Signaling Pathways in Cardiovascular Health and Disease—The Pros and Cons for Cardioprotection

The CD40–CD40 ligand (CD40L) dyad represents a scientific and clinical field that has raised many controversies in the past and cannot be clearly defined as being an either beneficial or harmful pathway. Being crucially involved in physiological immunological processes as well as pathological inflam...

Full description

Saved in:

Bibliographic Details
Published in:	International journal of molecular sciences Vol. 21; no. 22; p. 8533
Main Authors:	Daub, Steffen, Lutgens, Esther, Münzel, Thomas, Daiber, Andreas
Format:	Journal Article
Language:	English
Published:	Switzerland MDPI AG 12.11.2020 MDPI
Subjects:	Animals Atherosclerosis Atherosclerosis - metabolism Autoimmune Diseases - metabolism Binding sites Biomarkers Cardiovascular disease Cardiovascular Diseases - metabolism Cardiovascular System CD40 Antigens - metabolism CD40 Ligand - metabolism Clinical Trials as Topic Cytokines Diabetes Gene Silencing Heart attacks Humans Hypertension Immunomodulators Inflammation Kinases Ligands Lupus Mice Mice, Transgenic Proteins Psoriasis Review Rheumatoid arthritis Risk Factors Signal Transduction Smooth muscle Thrombosis Tumor necrosis factor-TNF atherosclerosis cardiovascular disease CD40 inflammation CD40 ligand
ISSN:	1422-0067, 1661-6596, 1422-0067
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!